nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—pancreatic cancer	0.701	1	CbGaD
Glipizide—CYP2C9—Tamoxifen—pancreatic cancer	0.0252	0.241	CbGbCtD
Glipizide—CYP2C9—Fluorouracil—pancreatic cancer	0.0186	0.177	CbGbCtD
Glipizide—CYP3A4—Tamoxifen—pancreatic cancer	0.0147	0.14	CbGbCtD
Glipizide—CYP3A4—Erlotinib—pancreatic cancer	0.0125	0.119	CbGbCtD
Glipizide—CYP3A4—Irinotecan—pancreatic cancer	0.0113	0.107	CbGbCtD
Glipizide—CYP3A4—Docetaxel—pancreatic cancer	0.00826	0.0787	CbGbCtD
Glipizide—CYP3A4—Sunitinib—pancreatic cancer	0.00822	0.0784	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—pancreatic cancer	0.00616	0.0587	CbGbCtD
Glipizide—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00451	1	CbGdCrCtD
Glipizide—KCNJ11—Type II diabetes mellitus—PDX1—pancreatic cancer	0.00171	0.0801	CbGpPWpGaD
Glipizide—Gliclazide—VEGFA—pancreatic cancer	0.00166	1	CrCbGaD
Glipizide—KCNJ11—Type II diabetes mellitus—SLC2A2—pancreatic cancer	0.00108	0.0505	CbGpPWpGaD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00102	0.0475	CbGpPWpGaD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.000985	0.046	CbGpPWpGaD
Glipizide—PPARG—Nuclear Receptors—NR5A2—pancreatic cancer	0.000905	0.0423	CbGpPWpGaD
Glipizide—PPARG—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.000715	0.0334	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—CHD3—pancreatic cancer	0.000662	0.031	CbGpPWpGaD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00064	0.0299	CbGpPWpGaD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.000621	0.029	CbGpPWpGaD
Glipizide—ABCC8—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.000438	0.0205	CbGpPWpGaD
Glipizide—KCNJ11—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.000425	0.0199	CbGpPWpGaD
Glipizide—ABCC8—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.000409	0.0191	CbGpPWpGaD
Glipizide—KCNJ11—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.000397	0.0185	CbGpPWpGaD
Glipizide—ABCC8—Integration of energy metabolism—GLP1R—pancreatic cancer	0.000345	0.0161	CbGpPWpGaD
Glipizide—KCNJ11—Integration of energy metabolism—GLP1R—pancreatic cancer	0.000334	0.0156	CbGpPWpGaD
Glipizide—ABCC8—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.000322	0.015	CbGpPWpGaD
Glipizide—KCNJ11—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.000312	0.0146	CbGpPWpGaD
Glipizide—ABCC8—Regulation of insulin secretion—GCG—pancreatic cancer	0.000304	0.0142	CbGpPWpGaD
Glipizide—KCNJ11—Regulation of insulin secretion—GCG—pancreatic cancer	0.000295	0.0138	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000255	0.0119	CbGpPWpGaD
Glipizide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000254	0.00153	CcSEcCtD
Glipizide—Rash—Tamoxifen—pancreatic cancer	0.000254	0.00153	CcSEcCtD
Glipizide—Dermatitis—Tamoxifen—pancreatic cancer	0.000254	0.00153	CcSEcCtD
Glipizide—Vomiting—Erlotinib—pancreatic cancer	0.000253	0.00152	CcSEcCtD
Glipizide—Dyspnoea—Irinotecan—pancreatic cancer	0.000253	0.00152	CcSEcCtD
Glipizide—Somnolence—Irinotecan—pancreatic cancer	0.000253	0.00152	CcSEcCtD
Glipizide—Headache—Tamoxifen—pancreatic cancer	0.000252	0.00152	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000252	0.00152	CcSEcCtD
Glipizide—Rash—Erlotinib—pancreatic cancer	0.000251	0.00151	CcSEcCtD
Glipizide—Dermatitis—Erlotinib—pancreatic cancer	0.000251	0.00151	CcSEcCtD
Glipizide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00025	0.00151	CcSEcCtD
Glipizide—Insomnia—Gemcitabine—pancreatic cancer	0.00025	0.00151	CcSEcCtD
Glipizide—Dyspepsia—Irinotecan—pancreatic cancer	0.00025	0.0015	CcSEcCtD
Glipizide—Headache—Erlotinib—pancreatic cancer	0.00025	0.0015	CcSEcCtD
Glipizide—Diplopia—Doxorubicin—pancreatic cancer	0.000249	0.0015	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000249	0.0015	CcSEcCtD
Glipizide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000249	0.0015	CcSEcCtD
Glipizide—Chills—Docetaxel—pancreatic cancer	0.000248	0.00149	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000248	0.00149	CcSEcCtD
Glipizide—Asthenia—Sunitinib—pancreatic cancer	0.000248	0.00149	CcSEcCtD
Glipizide—Decreased appetite—Irinotecan—pancreatic cancer	0.000247	0.00149	CcSEcCtD
Glipizide—Arrhythmia—Docetaxel—pancreatic cancer	0.000247	0.00149	CcSEcCtD
Glipizide—Dyspnoea—Gemcitabine—pancreatic cancer	0.000247	0.00148	CcSEcCtD
Glipizide—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000246	0.00148	CcSEcCtD
Glipizide—Insomnia—Fluorouracil—pancreatic cancer	0.000246	0.00148	CcSEcCtD
Glipizide—Somnolence—Gemcitabine—pancreatic cancer	0.000246	0.00148	CcSEcCtD
Glipizide—Migraine—Doxorubicin—pancreatic cancer	0.000246	0.00148	CcSEcCtD
Glipizide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000245	0.00148	CcSEcCtD
Glipizide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000244	0.00147	CcSEcCtD
Glipizide—KCNJ11—Type II diabetes mellitus—TNF—pancreatic cancer	0.000244	0.0114	CbGpPWpGaD
Glipizide—Pruritus—Sunitinib—pancreatic cancer	0.000244	0.00147	CcSEcCtD
Glipizide—Constipation—Irinotecan—pancreatic cancer	0.000243	0.00146	CcSEcCtD
Glipizide—Pain—Irinotecan—pancreatic cancer	0.000243	0.00146	CcSEcCtD
Glipizide—Dyspnoea—Fluorouracil—pancreatic cancer	0.000243	0.00146	CcSEcCtD
Glipizide—Somnolence—Fluorouracil—pancreatic cancer	0.000242	0.00146	CcSEcCtD
Glipizide—Erythema—Docetaxel—pancreatic cancer	0.000241	0.00145	CcSEcCtD
Glipizide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000241	0.00145	CcSEcCtD
Glipizide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00024	0.00144	CcSEcCtD
Glipizide—Nausea—Tamoxifen—pancreatic cancer	0.000239	0.00144	CcSEcCtD
Glipizide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000239	0.00144	CcSEcCtD
Glipizide—ABCC8—Integration of energy metabolism—GCG—pancreatic cancer	0.000239	0.0112	CbGpPWpGaD
Glipizide—Constipation—Gemcitabine—pancreatic cancer	0.000237	0.00142	CcSEcCtD
Glipizide—Pain—Gemcitabine—pancreatic cancer	0.000237	0.00142	CcSEcCtD
Glipizide—Nausea—Erlotinib—pancreatic cancer	0.000237	0.00142	CcSEcCtD
Glipizide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000237	0.00142	CcSEcCtD
Glipizide—Diarrhoea—Sunitinib—pancreatic cancer	0.000236	0.00142	CcSEcCtD
Glipizide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000235	0.00141	CcSEcCtD
Glipizide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000234	0.00141	CcSEcCtD
Glipizide—Pain—Fluorouracil—pancreatic cancer	0.000233	0.0014	CcSEcCtD
Glipizide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000232	0.0014	CcSEcCtD
Glipizide—KCNJ11—Integration of energy metabolism—GCG—pancreatic cancer	0.000232	0.0108	CbGpPWpGaD
Glipizide—Muscle spasms—Docetaxel—pancreatic cancer	0.000231	0.00139	CcSEcCtD
Glipizide—Dizziness—Sunitinib—pancreatic cancer	0.000228	0.00137	CcSEcCtD
Glipizide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000228	0.00137	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000228	0.00137	CcSEcCtD
Glipizide—Abdominal pain—Irinotecan—pancreatic cancer	0.000225	0.00135	CcSEcCtD
Glipizide—ABCC8—Integration of energy metabolism—STK11—pancreatic cancer	0.000225	0.0105	CbGpPWpGaD
Glipizide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000224	0.00135	CcSEcCtD
Glipizide—Pancytopenia—Epirubicin—pancreatic cancer	0.000221	0.00133	CcSEcCtD
Glipizide—Vomiting—Sunitinib—pancreatic cancer	0.000219	0.00132	CcSEcCtD
Glipizide—Dysuria—Epirubicin—pancreatic cancer	0.000218	0.00131	CcSEcCtD
Glipizide—KCNJ11—Integration of energy metabolism—STK11—pancreatic cancer	0.000218	0.0102	CbGpPWpGaD
Glipizide—Rash—Sunitinib—pancreatic cancer	0.000218	0.00131	CcSEcCtD
Glipizide—Dermatitis—Sunitinib—pancreatic cancer	0.000217	0.00131	CcSEcCtD
Glipizide—Urticaria—Fluorouracil—pancreatic cancer	0.000216	0.0013	CcSEcCtD
Glipizide—Headache—Sunitinib—pancreatic cancer	0.000216	0.0013	CcSEcCtD
Glipizide—Syncope—Docetaxel—pancreatic cancer	0.000216	0.0013	CcSEcCtD
Glipizide—Leukopenia—Docetaxel—pancreatic cancer	0.000215	0.0013	CcSEcCtD
Glipizide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000213	0.00128	CcSEcCtD
Glipizide—PPARG—Adipogenesis—AHR—pancreatic cancer	0.000212	0.00991	CbGpPWpGaD
Glipizide—Loss of consciousness—Docetaxel—pancreatic cancer	0.000212	0.00127	CcSEcCtD
Glipizide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000209	0.00126	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000208	0.00972	CbGpPWpGaD
Glipizide—Hypertension—Docetaxel—pancreatic cancer	0.000208	0.00125	CcSEcCtD
Glipizide—Drowsiness—Epirubicin—pancreatic cancer	0.000208	0.00125	CcSEcCtD
Glipizide—Arthralgia—Docetaxel—pancreatic cancer	0.000205	0.00123	CcSEcCtD
Glipizide—Myalgia—Docetaxel—pancreatic cancer	0.000205	0.00123	CcSEcCtD
Glipizide—Nausea—Sunitinib—pancreatic cancer	0.000205	0.00123	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—pancreatic cancer	0.000205	0.00123	CcSEcCtD
Glipizide—Asthenia—Irinotecan—pancreatic cancer	0.000204	0.00123	CcSEcCtD
Glipizide—Jaundice—Epirubicin—pancreatic cancer	0.000203	0.00122	CcSEcCtD
Glipizide—Conjunctivitis—Epirubicin—pancreatic cancer	0.000202	0.00121	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—pancreatic cancer	0.000202	0.00121	CcSEcCtD
Glipizide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000201	0.00121	CcSEcCtD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—TSC2—pancreatic cancer	0.0002	0.00937	CbGpPWpGaD
Glipizide—Sweating—Epirubicin—pancreatic cancer	0.000199	0.0012	CcSEcCtD
Glipizide—Asthenia—Gemcitabine—pancreatic cancer	0.000199	0.00119	CcSEcCtD
Glipizide—Confusional state—Docetaxel—pancreatic cancer	0.000198	0.00119	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000197	0.00118	CcSEcCtD
Glipizide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000196	0.00118	CcSEcCtD
Glipizide—Oedema—Docetaxel—pancreatic cancer	0.000196	0.00118	CcSEcCtD
Glipizide—Pruritus—Gemcitabine—pancreatic cancer	0.000196	0.00118	CcSEcCtD
Glipizide—Diarrhoea—Irinotecan—pancreatic cancer	0.000194	0.00117	CcSEcCtD
Glipizide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000194	0.00117	CcSEcCtD
Glipizide—Shock—Docetaxel—pancreatic cancer	0.000193	0.00116	CcSEcCtD
Glipizide—Pruritus—Fluorouracil—pancreatic cancer	0.000193	0.00116	CcSEcCtD
Glipizide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000192	0.00116	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—pancreatic cancer	0.000192	0.00116	CcSEcCtD
Glipizide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000189	0.00114	CcSEcCtD
Glipizide—Dizziness—Irinotecan—pancreatic cancer	0.000188	0.00113	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Glipizide—Anorexia—Docetaxel—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—pancreatic cancer	0.000187	0.00112	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000187	0.00112	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—pancreatic cancer	0.000187	0.00112	CcSEcCtD
Glipizide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000186	0.00112	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000186	0.00112	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—pancreatic cancer	0.000185	0.00111	CcSEcCtD
Glipizide—Sweating—Doxorubicin—pancreatic cancer	0.000184	0.00111	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000182	0.00109	CcSEcCtD
Glipizide—Vomiting—Irinotecan—pancreatic cancer	0.000181	0.00109	CcSEcCtD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.000181	0.00844	CbGpPWpGaD
Glipizide—Dizziness—Fluorouracil—pancreatic cancer	0.00018	0.00108	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—pancreatic cancer	0.00018	0.00108	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000179	0.00108	CcSEcCtD
Glipizide—Rash—Irinotecan—pancreatic cancer	0.000179	0.00108	CcSEcCtD
Glipizide—Dermatitis—Irinotecan—pancreatic cancer	0.000179	0.00108	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000179	0.00108	CcSEcCtD
Glipizide—Headache—Irinotecan—pancreatic cancer	0.000178	0.00107	CcSEcCtD
Glipizide—Insomnia—Docetaxel—pancreatic cancer	0.000178	0.00107	CcSEcCtD
Glipizide—Paraesthesia—Docetaxel—pancreatic cancer	0.000176	0.00106	CcSEcCtD
Glipizide—Vomiting—Gemcitabine—pancreatic cancer	0.000176	0.00106	CcSEcCtD
Glipizide—Dyspnoea—Docetaxel—pancreatic cancer	0.000175	0.00105	CcSEcCtD
Glipizide—Somnolence—Docetaxel—pancreatic cancer	0.000175	0.00105	CcSEcCtD
Glipizide—Rash—Gemcitabine—pancreatic cancer	0.000175	0.00105	CcSEcCtD
Glipizide—Dermatitis—Gemcitabine—pancreatic cancer	0.000174	0.00105	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—pancreatic cancer	0.000174	0.00105	CcSEcCtD
Glipizide—Headache—Gemcitabine—pancreatic cancer	0.000173	0.00104	CcSEcCtD
Glipizide—Flushing—Epirubicin—pancreatic cancer	0.000173	0.00104	CcSEcCtD
Glipizide—Vomiting—Fluorouracil—pancreatic cancer	0.000173	0.00104	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—pancreatic cancer	0.000173	0.00104	CcSEcCtD
Glipizide—Dyspepsia—Docetaxel—pancreatic cancer	0.000173	0.00104	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—pancreatic cancer	0.000173	0.00104	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000172	0.00103	CcSEcCtD
Glipizide—Rash—Fluorouracil—pancreatic cancer	0.000172	0.00103	CcSEcCtD
Glipizide—Dermatitis—Fluorouracil—pancreatic cancer	0.000171	0.00103	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000171	0.00103	CcSEcCtD
Glipizide—Decreased appetite—Docetaxel—pancreatic cancer	0.000171	0.00103	CcSEcCtD
Glipizide—Headache—Fluorouracil—pancreatic cancer	0.000171	0.00103	CcSEcCtD
Glipizide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00017	0.00102	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.000169	0.00791	CbGpPWpGaD
Glipizide—Nausea—Irinotecan—pancreatic cancer	0.000169	0.00102	CcSEcCtD
Glipizide—Pain—Docetaxel—pancreatic cancer	0.000168	0.00101	CcSEcCtD
Glipizide—Constipation—Docetaxel—pancreatic cancer	0.000168	0.00101	CcSEcCtD
Glipizide—Chills—Epirubicin—pancreatic cancer	0.000167	0.00101	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—pancreatic cancer	0.000167	0.001	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—pancreatic cancer	0.000166	0.001	CcSEcCtD
Glipizide—Nausea—Gemcitabine—pancreatic cancer	0.000164	0.000989	CcSEcCtD
Glipizide—Erythema—Epirubicin—pancreatic cancer	0.000162	0.000977	CcSEcCtD
Glipizide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000162	0.000974	CcSEcCtD
Glipizide—Nausea—Fluorouracil—pancreatic cancer	0.000162	0.000972	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—pancreatic cancer	0.000161	0.00097	CcSEcCtD
Glipizide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000161	0.000966	CcSEcCtD
Glipizide—Flushing—Doxorubicin—pancreatic cancer	0.00016	0.000963	CcSEcCtD
Glipizide—Flatulence—Epirubicin—pancreatic cancer	0.00016	0.000962	CcSEcCtD
Glipizide—Tension—Epirubicin—pancreatic cancer	0.000159	0.000958	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.000158	0.00738	CbGpPWpGaD
Glipizide—Nervousness—Epirubicin—pancreatic cancer	0.000158	0.000948	CcSEcCtD
Glipizide—PPARG—Adipogenesis—GADD45A—pancreatic cancer	0.000157	0.00735	CbGpPWpGaD
Glipizide—Muscle spasms—Epirubicin—pancreatic cancer	0.000156	0.000939	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—MET—pancreatic cancer	0.000155	0.00726	CbGpPWpGaD
Glipizide—Abdominal pain—Docetaxel—pancreatic cancer	0.000155	0.000934	CcSEcCtD
Glipizide—Chills—Doxorubicin—pancreatic cancer	0.000155	0.000931	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000154	0.000927	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—pancreatic cancer	0.000153	0.00092	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000151	0.000906	CcSEcCtD
Glipizide—Erythema—Doxorubicin—pancreatic cancer	0.00015	0.000904	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—AHR—pancreatic cancer	0.00015	0.00699	CbGpPWpGaD
Glipizide—Flatulence—Doxorubicin—pancreatic cancer	0.000148	0.00089	CcSEcCtD
Glipizide—Tension—Doxorubicin—pancreatic cancer	0.000147	0.000887	CcSEcCtD
Glipizide—Malaise—Epirubicin—pancreatic cancer	0.000146	0.000881	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—pancreatic cancer	0.000146	0.000878	CcSEcCtD
Glipizide—Vertigo—Epirubicin—pancreatic cancer	0.000146	0.000877	CcSEcCtD
Glipizide—Syncope—Epirubicin—pancreatic cancer	0.000146	0.000876	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—pancreatic cancer	0.000145	0.000874	CcSEcCtD
Glipizide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000145	0.000871	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000144	0.000869	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—NFKBIA—pancreatic cancer	0.000144	0.00673	CbGpPWpGaD
Glipizide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000143	0.000858	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—pancreatic cancer	0.000142	0.000852	CcSEcCtD
Glipizide—Asthenia—Docetaxel—pancreatic cancer	0.000141	0.000848	CcSEcCtD
Glipizide—Hypertension—Epirubicin—pancreatic cancer	0.00014	0.000843	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000139	0.000838	CcSEcCtD
Glipizide—Pruritus—Docetaxel—pancreatic cancer	0.000139	0.000836	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—pancreatic cancer	0.000139	0.00648	CbGpPWpGaD
Glipizide—Myalgia—Epirubicin—pancreatic cancer	0.000138	0.000831	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—pancreatic cancer	0.000138	0.000831	CcSEcCtD
Glipizide—Anxiety—Epirubicin—pancreatic cancer	0.000138	0.000829	CcSEcCtD
Glipizide—Discomfort—Epirubicin—pancreatic cancer	0.000137	0.000821	CcSEcCtD
Glipizide—Malaise—Doxorubicin—pancreatic cancer	0.000135	0.000815	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—RB1—pancreatic cancer	0.000135	0.00631	CbGpPWpGaD
Glipizide—Vertigo—Doxorubicin—pancreatic cancer	0.000135	0.000812	CcSEcCtD
Glipizide—Syncope—Doxorubicin—pancreatic cancer	0.000135	0.00081	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—pancreatic cancer	0.000134	0.000809	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatic cancer	0.000134	0.00628	CbGpPWpGaD
Glipizide—Diarrhoea—Docetaxel—pancreatic cancer	0.000134	0.000808	CcSEcCtD
Glipizide—Confusional state—Epirubicin—pancreatic cancer	0.000134	0.000804	CcSEcCtD
Glipizide—Oedema—Epirubicin—pancreatic cancer	0.000133	0.000797	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000132	0.000794	CcSEcCtD
Glipizide—Shock—Epirubicin—pancreatic cancer	0.00013	0.000784	CcSEcCtD
Glipizide—Dizziness—Docetaxel—pancreatic cancer	0.00013	0.000781	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00013	0.00078	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—pancreatic cancer	0.00013	0.00078	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatic cancer	0.000129	0.00602	CbGpPWpGaD
Glipizide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000128	0.00077	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—pancreatic cancer	0.000128	0.000769	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—pancreatic cancer	0.000128	0.000769	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—pancreatic cancer	0.000127	0.000767	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—pancreatic cancer	0.000126	0.00076	CcSEcCtD
Glipizide—Anorexia—Epirubicin—pancreatic cancer	0.000126	0.00076	CcSEcCtD
Glipizide—Vomiting—Docetaxel—pancreatic cancer	0.000125	0.000751	CcSEcCtD
Glipizide—Rash—Docetaxel—pancreatic cancer	0.000124	0.000745	CcSEcCtD
Glipizide—Dermatitis—Docetaxel—pancreatic cancer	0.000124	0.000744	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—pancreatic cancer	0.000124	0.000744	CcSEcCtD
Glipizide—PPARG—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000124	0.00577	CbGpPWpGaD
Glipizide—Headache—Docetaxel—pancreatic cancer	0.000123	0.00074	CcSEcCtD
Glipizide—Oedema—Doxorubicin—pancreatic cancer	0.000123	0.000737	CcSEcCtD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—CCND1—pancreatic cancer	0.000121	0.00567	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000121	0.000726	CcSEcCtD
Glipizide—Shock—Doxorubicin—pancreatic cancer	0.000121	0.000726	CcSEcCtD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—pancreatic cancer	0.00012	0.00562	CbGpPWpGaD
Glipizide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00012	0.000722	CcSEcCtD
Glipizide—Insomnia—Epirubicin—pancreatic cancer	0.00012	0.000721	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—pancreatic cancer	0.000119	0.000716	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN2A—pancreatic cancer	0.000119	0.00555	CbGpPWpGaD
Glipizide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000119	0.000713	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—pancreatic cancer	0.000118	0.000711	CcSEcCtD
Glipizide—Somnolence—Epirubicin—pancreatic cancer	0.000118	0.000709	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—pancreatic cancer	0.000117	0.000703	CcSEcCtD
Glipizide—Nausea—Docetaxel—pancreatic cancer	0.000117	0.000702	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—pancreatic cancer	0.000117	0.000702	CcSEcCtD
Glipizide—PPARG—Developmental Biology—ACVR1B—pancreatic cancer	0.000116	0.00543	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NR5A2—pancreatic cancer	0.000116	0.00543	CbGpPWpGaD
Glipizide—Decreased appetite—Epirubicin—pancreatic cancer	0.000115	0.000693	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000114	0.000688	CcSEcCtD
Glipizide—Constipation—Epirubicin—pancreatic cancer	0.000113	0.000682	CcSEcCtD
Glipizide—Pain—Epirubicin—pancreatic cancer	0.000113	0.000682	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—EZH2—pancreatic cancer	0.000113	0.00528	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000112	0.000672	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—pancreatic cancer	0.000111	0.000667	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—pancreatic cancer	0.00011	0.000662	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000109	0.000657	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000109	0.000657	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—pancreatic cancer	0.000109	0.000656	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000108	0.000652	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000108	0.000649	CcSEcCtD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000108	0.00503	CbGpPWpGaD
Glipizide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000107	0.000641	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000106	0.000637	CcSEcCtD
Glipizide—Urticaria—Epirubicin—pancreatic cancer	0.000105	0.000633	CcSEcCtD
Glipizide—PPARG—Developmental Biology—PDX1—pancreatic cancer	0.000105	0.00491	CbGpPWpGaD
Glipizide—Pain—Doxorubicin—pancreatic cancer	0.000105	0.000631	CcSEcCtD
Glipizide—Constipation—Doxorubicin—pancreatic cancer	0.000105	0.000631	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—pancreatic cancer	0.000105	0.00063	CcSEcCtD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000104	0.00488	CbGpPWpGaD
Glipizide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000101	0.000608	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—CCND1—pancreatic cancer	0.0001	0.00469	CbGpPWpGaD
Glipizide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.0001	0.000603	CcSEcCtD
Glipizide—Hypersensitivity—Epirubicin—pancreatic cancer	9.76e-05	0.000587	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—pancreatic cancer	9.74e-05	0.000586	CcSEcCtD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—MYC—pancreatic cancer	9.74e-05	0.00455	CbGpPWpGaD
Glipizide—Abdominal pain—Doxorubicin—pancreatic cancer	9.69e-05	0.000583	CcSEcCtD
Glipizide—PPARG—Adipogenesis—HIF1A—pancreatic cancer	9.65e-05	0.00451	CbGpPWpGaD
Glipizide—Asthenia—Epirubicin—pancreatic cancer	9.51e-05	0.000572	CcSEcCtD
Glipizide—Pruritus—Epirubicin—pancreatic cancer	9.37e-05	0.000564	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatic cancer	9.36e-05	0.00437	CbGpPWpGaD
Glipizide—Diarrhoea—Epirubicin—pancreatic cancer	9.07e-05	0.000545	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—pancreatic cancer	9.03e-05	0.000543	CcSEcCtD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	8.84e-05	0.00413	CbGpPWpGaD
Glipizide—Asthenia—Doxorubicin—pancreatic cancer	8.8e-05	0.000529	CcSEcCtD
Glipizide—Dizziness—Epirubicin—pancreatic cancer	8.76e-05	0.000527	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—pancreatic cancer	8.67e-05	0.000522	CcSEcCtD
Glipizide—PPARG—Developmental Biology—NRP1—pancreatic cancer	8.57e-05	0.00401	CbGpPWpGaD
Glipizide—Vomiting—Epirubicin—pancreatic cancer	8.42e-05	0.000507	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—pancreatic cancer	8.39e-05	0.000505	CcSEcCtD
Glipizide—Rash—Epirubicin—pancreatic cancer	8.35e-05	0.000503	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—pancreatic cancer	8.35e-05	0.000502	CcSEcCtD
Glipizide—Headache—Epirubicin—pancreatic cancer	8.3e-05	0.000499	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—STAT3—pancreatic cancer	8.26e-05	0.00386	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TYMS—pancreatic cancer	8.17e-05	0.00382	CbGpPWpGaD
Glipizide—Dizziness—Doxorubicin—pancreatic cancer	8.11e-05	0.000488	CcSEcCtD
Glipizide—Nausea—Epirubicin—pancreatic cancer	7.87e-05	0.000473	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.86e-05	0.00367	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—RB1—pancreatic cancer	7.85e-05	0.00367	CbGpPWpGaD
Glipizide—Vomiting—Doxorubicin—pancreatic cancer	7.8e-05	0.000469	CcSEcCtD
Glipizide—Rash—Doxorubicin—pancreatic cancer	7.73e-05	0.000465	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—pancreatic cancer	7.72e-05	0.000465	CcSEcCtD
Glipizide—Headache—Doxorubicin—pancreatic cancer	7.68e-05	0.000462	CcSEcCtD
Glipizide—Nausea—Doxorubicin—pancreatic cancer	7.28e-05	0.000438	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—TNF—pancreatic cancer	7.15e-05	0.00334	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CHD3—pancreatic cancer	7.1e-05	0.00332	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—pancreatic cancer	7.1e-05	0.00332	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MEN1—pancreatic cancer	7.09e-05	0.00332	CbGpPWpGaD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—AKT1—pancreatic cancer	6.75e-05	0.00316	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH4—pancreatic cancer	6.72e-05	0.00314	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SLC2A2—pancreatic cancer	6.63e-05	0.0031	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—pancreatic cancer	6.63e-05	0.0031	CbGpPWpGaD
Glipizide—PPARG—SREBP signalling—PIK3CA—pancreatic cancer	6.59e-05	0.00308	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PRSS1—pancreatic cancer	6.45e-05	0.00302	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IAPP—pancreatic cancer	6.29e-05	0.00294	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PRSS1—pancreatic cancer	6.26e-05	0.00292	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR5A2—pancreatic cancer	5.95e-05	0.00278	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.83e-05	0.00272	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—CTNNB1—pancreatic cancer	5.78e-05	0.0027	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH3—pancreatic cancer	5.72e-05	0.00267	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ARG2—pancreatic cancer	5.59e-05	0.00261	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ARG2—pancreatic cancer	5.42e-05	0.00254	CbGpPWpGaD
Glipizide—PPARG—SREBP signalling—AKT1—pancreatic cancer	5.39e-05	0.00252	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.11e-05	0.00239	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—STAT3—pancreatic cancer	5.03e-05	0.00235	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TYMP—pancreatic cancer	4.89e-05	0.00229	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TYMP—pancreatic cancer	4.74e-05	0.00222	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TGFB1—pancreatic cancer	4.67e-05	0.00218	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PRSS1—pancreatic cancer	4.62e-05	0.00216	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—pancreatic cancer	4.36e-05	0.00204	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—SMAD4—pancreatic cancer	4.31e-05	0.00201	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SMAD4—pancreatic cancer	4.05e-05	0.00189	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ARG2—pancreatic cancer	4.01e-05	0.00187	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—PTEN—pancreatic cancer	3.97e-05	0.00186	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HES1—pancreatic cancer	3.96e-05	0.00185	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GLP1R—pancreatic cancer	3.94e-05	0.00184	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—DPYD—pancreatic cancer	3.88e-05	0.00181	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GLP1R—pancreatic cancer	3.82e-05	0.00179	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—DPYD—pancreatic cancer	3.76e-05	0.00176	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC2A2—pancreatic cancer	3.68e-05	0.00172	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC2A2—pancreatic cancer	3.57e-05	0.00167	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMP—pancreatic cancer	3.5e-05	0.00164	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MEN1—pancreatic cancer	3.42e-05	0.0016	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH4—pancreatic cancer	3.24e-05	0.00151	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	3.17e-05	0.00148	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KDR—pancreatic cancer	3.17e-05	0.00148	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MET—pancreatic cancer	3.1e-05	0.00145	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HSPA1B—pancreatic cancer	3.09e-05	0.00144	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NOTCH1—pancreatic cancer	2.99e-05	0.0014	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.89e-05	0.00135	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CD44—pancreatic cancer	2.85e-05	0.00133	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GLP1R—pancreatic cancer	2.82e-05	0.00132	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—EZH2—pancreatic cancer	2.81e-05	0.00131	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—HRAS—pancreatic cancer	2.78e-05	0.0013	CbGpPWpGaD
Glipizide—PPARG—Metabolism—DPYD—pancreatic cancer	2.78e-05	0.0013	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CD44—pancreatic cancer	2.76e-05	0.00129	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH3—pancreatic cancer	2.75e-05	0.00129	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GCG—pancreatic cancer	2.73e-05	0.00128	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—pancreatic cancer	2.71e-05	0.00127	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—HRAS—pancreatic cancer	2.7e-05	0.00126	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GCG—pancreatic cancer	2.65e-05	0.00124	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC2A2—pancreatic cancer	2.64e-05	0.00123	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.61e-05	0.00122	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HSPA1A—pancreatic cancer	2.61e-05	0.00122	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP2—pancreatic cancer	2.59e-05	0.00121	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—STK11—pancreatic cancer	2.57e-05	0.0012	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—STK11—pancreatic cancer	2.49e-05	0.00116	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.29e-05	0.00107	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TYMS—pancreatic cancer	2.21e-05	0.00103	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TYMS—pancreatic cancer	2.14e-05	0.001	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SMAD4—pancreatic cancer	2.07e-05	0.000969	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CD44—pancreatic cancer	2.04e-05	0.000955	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2e-05	0.000935	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CTNNB1—pancreatic cancer	1.99e-05	0.000928	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.98e-05	0.000926	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GCG—pancreatic cancer	1.96e-05	0.000915	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—pancreatic cancer	1.95e-05	0.00091	CbGpPWpGaD
Glipizide—PPARG—Metabolism—STK11—pancreatic cancer	1.84e-05	0.00086	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—pancreatic cancer	1.8e-05	0.00084	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—pancreatic cancer	1.79e-05	0.000839	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—pancreatic cancer	1.75e-05	0.000817	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—pancreatic cancer	1.74e-05	0.000814	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—pancreatic cancer	1.73e-05	0.000809	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.73e-05	0.000808	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NRAS—pancreatic cancer	1.73e-05	0.000807	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—pancreatic cancer	1.71e-05	0.000798	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.7e-05	0.000796	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—pancreatic cancer	1.62e-05	0.000758	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—pancreatic cancer	1.6e-05	0.00075	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMS—pancreatic cancer	1.58e-05	0.00074	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—pancreatic cancer	1.57e-05	0.000735	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—pancreatic cancer	1.57e-05	0.000735	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—pancreatic cancer	1.57e-05	0.000732	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH1—pancreatic cancer	1.53e-05	0.000714	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—pancreatic cancer	1.52e-05	0.000709	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—pancreatic cancer	1.5e-05	0.0007	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—pancreatic cancer	1.49e-05	0.000694	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.48e-05	0.00069	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—pancreatic cancer	1.43e-05	0.000666	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—pancreatic cancer	1.38e-05	0.000646	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.29e-05	0.000603	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—pancreatic cancer	1.29e-05	0.000602	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—pancreatic cancer	1.26e-05	0.00059	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—pancreatic cancer	1.24e-05	0.000581	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—pancreatic cancer	1.23e-05	0.000576	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.22e-05	0.00057	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—pancreatic cancer	1.2e-05	0.000563	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—pancreatic cancer	1.19e-05	0.000558	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—pancreatic cancer	1.16e-05	0.000543	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.12e-05	0.000525	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—pancreatic cancer	1.12e-05	0.000521	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—pancreatic cancer	1.07e-05	0.000502	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.06e-05	0.000498	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—pancreatic cancer	1.04e-05	0.000487	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.04e-05	0.000486	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.02e-05	0.000478	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—pancreatic cancer	1.02e-05	0.000478	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.74e-06	0.000455	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	9.71e-06	0.000454	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.61e-06	0.000449	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.28e-06	0.000434	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—pancreatic cancer	8.91e-06	0.000416	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—pancreatic cancer	8.82e-06	0.000412	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.51e-06	0.000398	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.45e-06	0.000395	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—pancreatic cancer	8.22e-06	0.000384	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—pancreatic cancer	7.7e-06	0.00036	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—pancreatic cancer	7.58e-06	0.000354	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD44—pancreatic cancer	7.52e-06	0.000352	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.36e-06	0.000344	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—pancreatic cancer	7.35e-06	0.000343	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.3e-06	0.000341	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCG—pancreatic cancer	7.21e-06	0.000337	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.86e-06	0.000321	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—STK11—pancreatic cancer	6.78e-06	0.000317	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.75e-06	0.000315	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.4e-06	0.000299	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.36e-06	0.000297	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—pancreatic cancer	6.19e-06	0.000289	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—pancreatic cancer	6e-06	0.00028	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.83e-06	0.000273	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—pancreatic cancer	5.7e-06	0.000267	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—pancreatic cancer	5.43e-06	0.000254	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD44—pancreatic cancer	4.96e-06	0.000232	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCG—pancreatic cancer	4.76e-06	0.000222	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—pancreatic cancer	4.74e-06	0.000222	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.49e-06	0.00021	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STK11—pancreatic cancer	4.47e-06	0.000209	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—pancreatic cancer	4.43e-06	0.000207	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.28e-06	0.0002	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—pancreatic cancer	4.13e-06	0.000193	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.85e-06	0.00018	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.76e-06	0.000176	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.28e-06	0.000153	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.25e-06	0.000152	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—pancreatic cancer	3.13e-06	0.000146	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.83e-06	0.000132	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.82e-06	0.000132	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.72e-06	0.000127	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.48e-06	0.000116	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.16e-06	0.000101	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.14e-06	0.0001	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2e-06	9.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.87e-06	8.74e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.63e-06	7.63e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.32e-06	6.16e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.08e-06	5.03e-05	CbGpPWpGaD
